Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rare cancers of childhood (NCI PDQ umbrella), Germline vs somatic mutations, Hereditary cancer syndromes, Cabozantinib and the tags rare, endocrine.
Shares Multiple endocrine neoplasia type 2 (MEN2A and MEN2B), Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Medullary thyroid cancer, Peptide receptor radionuclide therapy (PRRT) and the tag endocrine.
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Somatostatin analogues (octreotide, lanreotide), Peptide receptor radionuclide therapy (PRRT), Menin and the tag endocrine.
Shares MEN1 and hereditary neuroendocrine syndromes, Multiple endocrine neoplasia type 1 (MEN1), Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Somatostatin analogues (octreotide, lanreotide) and the tag endocrine.
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Peptide receptor radionuclide therapy (PRRT), Pheochromocytoma and paraganglioma (PPGL), Somatostatin receptor 2 and the tag endocrine.
Shares Germline vs somatic mutations, Hereditary cancer syndromes, Neuroendocrine tumours and the tag hereditary.
Shares Multiple endocrine neoplasia type 1 (MEN1), Peptide receptor radionuclide therapy (PRRT), Sunitinib, Everolimus and the tag rare.
Shares Multiple endocrine neoplasia type 1 (MEN1), Peptide receptor radionuclide therapy (PRRT), Sunitinib, Everolimus and the tag rare.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.